This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Ikena Oncology, Inc.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Oksana Zavidij: Innovator in MEK Inhibitors
Introduction
Oksana Zavidij is a prominent inventor based in Westminster, MA (US). She has made significant contributions to the field of oncology through her innovative work on MEK inhibitors. With a total of two patents to her name, Zavidij is recognized for her dedication to advancing cancer treatment.
Latest Patents
Zavidij's latest patents focus on MEK inhibitors and their applications. The first patent provides detailed information on MEK inhibitors, compositions thereof, and methods of using the same. The second patent reiterates these findings, emphasizing the importance of MEK inhibitors in therapeutic contexts.
Career Highlights
Oksana Zavidij is currently employed at Ikena Oncology, Inc., where she continues to develop groundbreaking treatments for cancer. Her work is instrumental in the ongoing research and development of effective oncology therapies.
Collaborations
Zavidij collaborates with notable colleagues, including Michael J. Burke and Thomas A. Wynn. These partnerships enhance her research efforts and contribute to the advancement of innovative cancer treatments.
Conclusion
Oksana Zavidij is a trailblazer in the field of oncology, with her work on MEK inhibitors paving the way for new therapeutic options. Her contributions are vital to the ongoing fight against cancer, and her innovative spirit continues to inspire others in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile